Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Novel Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Expresses Anti-Mycobacterium abscessus Activity In Vitro and In Vivo
Wenye Wu, Siyuan He, Anqi Li, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 9
Open Access | Times Cited: 13

Showing 13 citing articles:

Exploring antibiotic resistance mechanisms in Mycobacterium abscessus for enhanced therapeutic approaches
Thanh Quang Nguyen, Bo Eun Heo, Seunghyeon Jeon, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 9
Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations
Véronique Dartois, Tracey L. Bonfield, Jim P. Boyce, et al.
Tuberculosis (2024) Vol. 147, pp. 102503-102503
Closed Access | Times Cited: 7
LeuRS‐Targeting Prodrug, MRX‐5, Expresses Anti‐Mycobacterium abscessus Activity
Anqi Li, Siyuan He, Yaping Jia, et al.
Clinical and Experimental Pharmacology and Physiology (2025) Vol. 52, Iss. 4
Closed Access
Alternative therapies against Mycobacterium abscessus infections
Ivana Palucci, Giovanni Delogu
Clinical Microbiology and Infection (2023) Vol. 30, Iss. 6, pp. 732-737
Open Access | Times Cited: 9
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division
Giulia Degiacomi, Laurent R. Chiarelli, Olga Riabova, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 4, pp. 107278-107278
Open Access | Times Cited: 3
DS86760016, a Leucyl-tRNA Synthetase Inhibitor, Is Active against Mycobacterium abscessus
Thanh Quang Nguyen, Bo Eun Heo, Bui Thi Bich Hanh, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 6
Open Access | Times Cited: 8
Why Matter Matters: Fast-Tracking Mycobacterium abscessus Drug Discovery
Uday S. Ganapathy, Thomas Dick
Molecules (2022) Vol. 27, Iss. 20, pp. 6948-6948
Open Access | Times Cited: 13
Toward better cures for Mycobacterium abscessus lung disease
Véronique Dartois, Thomas Dick
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 2
Oral oxaborole MRX-5 exhibits efficacy against pulmonary Mycobacterium abscessus in mouse
Binayak Rimal, Ruth A. Howe, Chandra M. Panthi, et al.
Antimicrobial Agents and Chemotherapy (2024)
Open Access | Times Cited: 1
An open-access dashboard to interrogate the genetic diversity of Mycobacterium tuberculosis clinical isolates
Jody Phelan, Klaas Van den Heede, Serge Masyn, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Moles of Molecules against Mycobacterium abscessus: A Review of Current Research
Mario Cocorullo, C Bettoni, Sara Foiadelli, et al.
Future Pharmacology (2023) Vol. 3, Iss. 3, pp. 637-663
Open Access | Times Cited: 3
TBAJ-587, a novel diarylquinoline, is active against Mycobacterium abscessus
Junsheng Fan, Zhili Tan, Siyuan He, et al.
Antimicrobial Agents and Chemotherapy (2024)
Open Access
FL058, a novel β-lactamase inhibitor, increases the anti-Mycobacterium abscessus activity of imipenem
Zhili Tana, Yani Lin, Junsheng Fan, et al.
International Journal of Antimicrobial Agents (2024), pp. 107414-107414
Closed Access
Page 1

Scroll to top